BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nielsen AY, Ormhøj M, Traynor S, Gjerstorff MF. Augmenting engineered T-cell strategies in solid cancers through epigenetic priming. Cancer Immunol Immunother 2020;69:2169-78. [PMID: 32648166 DOI: 10.1007/s00262-020-02661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gokuldass A, Schina A, Lauss M, Harbst K, Chamberlain CA, Draghi A, Westergaard MCW, Nielsen M, Papp K, Sztupinszki Z, Csabai I, Svane IM, Szallasi Z, Jönsson G, Donia M. Transcriptomic signatures of tumors undergoing T cell attack. Cancer Immunol Immunother 2021. [PMID: 34272988 DOI: 10.1007/s00262-021-03015-1] [Reference Citation Analysis]
2 Ohkuri T, Kosaka A, Ikeura M, Salazar AM, Okada H. IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity. J Immunother Cancer 2021;9:e002426. [PMID: 34193567 DOI: 10.1136/jitc-2021-002426] [Reference Citation Analysis]